15 articles with MicroVention, Inc.
MicroVention Announces Positive Safety And Effectiveness Results In Web-It Pivotal Trial Published In Journal Of NeuroInterventional Surgery
The WEB-IT pivotal trial highlights positive clinical outcomes with the WEB® Aneurysm Embolization System, the only intrasaccular flow disruptor approved in the United States.
The WEB® Aneurysm Embolization System is the first intrasaccular flow disruptor PMA approved for the embolization of wide neck bifurcation aneurysms
SOFIA® Catheter; A New Device for the Revascularization of Patients with Acute Ischemic Stroke
The LVIS® and LVIS® Jr. stents are the first stents PMA approved for stent-assisted coil embolization
MicroVention, Inc. Announces First Trial Enrollment in Their U.S. Clinical Trial of Its New Dual-Layer Stent for Cerebral Aneurysm Flow Diversion
MicroVention, Inc.'s New Manufacturing Plant Facility in Costa Rica Celebrates Grand Opening With Inaugural Plant Ceremony
MicroVention, Inc. Announces First Patient Enrollment in Clinical Trial to Compare Coiling Technologies for Treating Brain Aneurysms
MicroVention, Inc. Release: Final Published Trial Data in The Lancet Supports Safety and Effectiveness of MicroVention-Terumo's HydroCoil® Embolic System for Treatment of Cerebral Aneurysms
MicroVention, Inc., Terumo Corporation: Final Data in International Trial Supports Safety and Effectiveness of MicroVention-Terumo's HydroCoil(R) Embolic System for Treatment of Cerebral Aneurysms